Nachrichten zur McKesson Corp. Aktie

MCK Stock Down Despite Latest Partnership to Boost SCD Treatment

The availability of the FDA-approved drug via McKessons cell and gene therapies business is expected to give patients improved treatment…

McKesson Stock Gains 34.1% YTD: Whats Driving the Rally?

MCK continues to gain because of robust segmental performance and raised fiscal 2025 guidance.…

5 Stocks That Look Promising Following Broker Rating Upgrades

Investors should monitor stocks like American Airlines, Air Canada, DXC, Dollar General, and McKesson for high returns.…

McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network

…

McKesson (MCK) Q2 2025 Earnings Call Transcript

MCK earnings call for the period ending September 30, 2024.…

MCK Stock Gains as Q2 Earnings & Sales Top Estimates, 25 EPS View Up

McKessons second-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower…

Do Options Traders Know Something About McKesson (MCK) Stock We Dont?

Investors need to pay close attention to McKesson (MCK) stock based on the movements in the options market lately.…

McKesson: The Correction Is Not Over

…

MCK Stocks Uptrend Likely to Continue After Core Ventures Acquisition

McKessons agreement to acquire a controlling interest will likely bring advanced treatments and improved care experiences to patients.…

McKesson to Buy Stake in Florida Cancer Chain for $2.49 Billion

McKesson Corp. agreed to buy a controlling stake in an arm of Florida Cancer Specialists & Research Institute, a privately…

Global Teleradiology Market Analysis and Competitive Landscape Report 2024-2032 Featuring FUJIFILM, Koninklijke Philips, General Electric, Oracle, Siemens, GE HEALTHCARE, and McKesson

Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "Global Teleradiology Market Report by Technology Imaging Techniques End Users…

McKesson (MCK) Stock Gains 18% YTD: Whats Driving the Rally?

McKessons (MCK) shares rally on the back of solid fundamentals. Increasing volumes of prescription and specialty drugs boost the top…

McKesson (MCK) Q1 2025 Earnings Call Transcript

MCK earnings call for the period ending June 30, 2024.…

McKesson (MCK) Q1 Earnings Beat Estimates, Revenues Up Y/Y

McKessons (MCK) first-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to…

McKesson: Sprungbrett Seitwärtskonsolidierung - Chartanalyse

Paris (www.aktiencheck.de) - McKesson: Sprungbrett Seitwärtskonsolidierung - Chartanalyse Die McKesson-Aktie (ISIN: US58155Q1031, WKN: 893953, Ticker-Symbol: MCK, NYSE-Symbol: MCK) befindet sich in…

Should You Buy, Sell or Hold McKesson (MCK) Before Q1 Earnings?

McKessons (MCK) first-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions…

McKesson, Cardinal, Cencora interested in buying private cancer clinics - report

…

McKesson, Cencora and Cardinal Health Circle Florida Cancer Specialists

Several publicly traded drug distributors are vying to buy Florida Cancer Specialists & Research Institute, a privately held operator of…

McKesson (MCK) Gains 26% Year to Date: Whats Backing the Rally?

McKessons (MCK) shares have risen 1.5% year to date on the back of solid fundamentals. Increasing volumes of prescription and…

3 Reasons Why You Should Hold McKesson (MCK) Stock for Now

McKessons (MCK) robust Biologics business raises optimism about the stock.…

McKesson: Erholung in der Abwärtsbewegung - Chartanalyse

Paris (www.aktiencheck.de) - McKesson: Erholung in der Abwärtsbewegung - Chartanalyse Die McKesson-Aktie (ISIN: US58155Q1031, WKN: 893953, Ticker-Symbol: MCK, NYSE-Symbol: MCK) befindet…

McKesson: Hochlauf nach Bullenkerze - Chartanalyse

Paris (www.aktiencheck.de) - McKesson-Chartanalyse der BNP Paribas: Rückblick: Die Aktie von McKesson (ISIN: US58155Q1031, WKN: 893953, Ticker-Symbol: MCK, NYSE-Symbol: MCK) befindet…

dailyAKTIEN: McKesson - Hochlauf nach Bullenkerze

…

McKesson (MCK) Reaches 52-Week High: Whats Aiding the Stock?

Investors are optimistic about McKessons (MCK) strength in its Biologics business.…

McKesson (MCK) Introduces FDA-Approved Prostate Cancer Drug

The availability of the FDA-approved drug via McKessons (MCK) independent specialty pharmacy is expected to give patients improved treatment options…

McKesson (MCK) Gains 26% YTD: Whats Driving the Rally?

McKessons (MCK) shares have risen year to date on the back of strong fundamentals. Rising volumes of prescription and specialty…

Heres Why You Should Hold McKesson (MCK) in Your Portfolio Now

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.…

McKesson: Steigend wegen Saisonalität - Chartanalyse

Paris (www.aktiencheck.de) - McKesson-Chartanalyse der BNP Paribas: Rückblick: Die McKesson-Aktie (ISIN: US58155Q1031, WKN: 893953, Ticker-Symbol: MCK, NYSE-Symbol: MCK) befindet sich in…

McKesson (MCK) Hits 52-Week High: Whats Driving the Stock?

Investors are optimistic about McKessons (MCK) strength in its Biologics business.…

McKesson (MCK) Q4 2024 Earnings Call Transcript

MCK earnings call for the period ending March 31, 2024.…

McKesson (MCK) Q4 Earnings Miss Estimates, Revenues Up Y/Y

McKessons (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical…

McKesson (MCK) to Report Q4 Earnings: Whats in the Cards?

McKessons (MCK) fourth-quarter fiscal 2024 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions…

McKesson: Time To Get More Cautious

…

How Cabinet Health Is Pioneering Sustainable Healthcare, One Plastic-Free Pill Bottle At A Time

Cabinet Health is on a mission to reduce single-use plastic from healthcare and they have found like-minded partners in major…

Aktie der Woche: McKesson mit neuem Allzeit-Hoch

Bernd (Gurupress.de) - Liebe Leser, liebe Leserinnen, hoch, höher, McKesson. Der Techaktien-Masterclass Dauerläufer McKesson hat in der zurückliegenden Handelswoche abermals…

McKesson (MCK) Hits 52-Week High: Whats Driving the Stock?

Investors are optimistic about McKessons (MCK) strength in its Biologics business.…

Rite Aid reaches bankruptcy settlement with lenders, DOJ, McKesson

Pharmacy chain Rite Aid has reached a settlement with its lenders, the U.S. Department of Justice, and drug supplier McKesson…

Rite Aid reaches bankruptcy settlement with lenders, DOJ, McKesson By Reuters

Rite Aid reaches bankruptcy settlement with lenders, DOJ, McKesson…

Heres Why You Should Hold McKesson (MCK) in Your Portfolio

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.…

McKesson CEO sells over $1.8 million in company stock By Investing.com

McKesson CEO sells over $1.8 million in company stock…

McKesson whistleblowers kickback lawsuit is revived By Reuters

McKesson whistleblowers kickback lawsuit is revived…

McKesson: GLP-1 Contributed More Than 1/3 Of Growth

…

Pharma Stocks: 5 Biggest Companies in 2024

The pharmaceutical industry is a major player in the life science sector, responsible for developing and manufacturing the majority of…

McKesson (MCK) Beats on Q3 Earnings, Raises FY24 EPS View

McKessons (MCK) third-quarter fiscal 2024 results benefit from growth in the United States. Divestment hurts the International segment.…

5 Dividend Growth Stocks to Buy for a Safe Portfolio

Installed Building Products (IBP), PACCAR. (PCAR), McKesson (MCK), Republic Services (RSG) and PulteGroup (PHM) seem solid choices for a safe…

McKesson (MCK) to Report Q3 Earnings: Whats in the Cards?

McKessons (MCK) third-quarter fiscal 2024 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions…

Disney, Caterpillar, McDonalds, Ford: Investing Action Plan

Disney stock heads a handful of Dow Jones names reporting, with Ford and McKesson also on the calendar for the…

Kurs von McKesson steigt etwas (466,5041 €)

Im Plus liegt aktuell die Aktie von McKesson . Das Wertpapier kostete zuletzt 503,26 US-Dollar. Ein Preisanstieg von 0,28 Prozent…

McKesson: Why The Company Is Too Richly Valued

…

McKesson (MCK) Set to Sell Canadian Rexall Pharmacy Group

McKesson (MCK) is seeking buyers for the Canadian Rexall Pharmacy Group. The business is currently amid its second round of…